Alzheimer’s Research & Therapy publishes first research article

Persistence pays off, at least that is the
message from Rountree et al.
in the first research article published in Alzheimer’s Research
& Therapy
This article, ‘Persistent treatment with cholinesterase
inhibitors and/or memantine slows clinical progression of Alzheimer’s disease
(AD)
’ reports their findings that persistent
treatment
had a
positive impact on Alzheimer’s disease (AD) progression by multiple cognitive
and functional outcome measures.

Alzheimer’s
Research & Therapy
publishes basic research with a
translational focus, as well as looking at animal models of disease,
biomarkers, clinical trials, and research into drug discovery and development.
Although the primary focus is Alzheimer’s dementia, the scope will encompass
translational research into other neurodegenerative diseases.
 

The
Editors-in-Chief of
Alzheimer’s Research & Therapy
are Professors Douglas Galasko, Todd Golde, and
Gordon Wilcock, who are supported by an exceptional international
Editorial Board.

Submit your next manuscript to Alzheimer’s Research
& Therapy
to join the pioneering authors who are publishing in this
exciting journal. For more details about the journal, please visit the journal
information page, or contact the
editorial
office
. To keep up to date with the latest developments, news and articles
being published in this exciting, please
register
to receive regular alerts.

Frances Mulvany
In-house Editor –
Alzheimer’s Research & Therapy

View the latest posts on the On Medicine homepage

Comments

By commenting, you’re agreeing to follow our community guidelines.

Your email address will not be published. Required fields are marked *